John Maki

Vicus Therapeutics, President and Chief Executive Officer

John Maki previously served as Managing Director of Technology Directors, Inc., as Managing Director of Audax Group and as Principal, Bain Capital, as well as consultant, Bain & Company.

Mr. Maki holds an AB degree from Harvard University. Mr. Maki has over 25 years of industry experience and has been founding investor and/or board member of eleven life science companies. In addition, four of Mr. Maki’s portfolio companies had successful IPOs and grew to a combined market capitalization exceeding $2.5 billion dollars. Mr. Maki currently serves on the boards of 3DMatrix, a wound healing device company and Vicus Therapeutics. Mr. Maki also serves on the Board of Trustees of BioNJ.